6-11 cases per 1 000 000 population aged <15 years (12-29 per 1 000 000 aged <4 years) in Japan [23] . Among these cases, A/ H2N3 was the most frequently identified influenza subtype, although A/H1N1 and influenza B have also been reported [22, 23] . Among other cohorts, IAE has occurred in 1%-3% of hospitalized influenza [9, 18, 20, 24] .
There are few longitudinal studies of seasonal IAND [25] , only 1 from outside East Asia [7] , and none from the Southern Hemisphere. Here, we aimed to characterize the burden and contemporary clinical spectrum of IAND in hospitalized children over the 3 study year seasons (2013-2015) using sentinel site surveillance from 2 established and complementary networks based in pediatric hospitals in Australia.
METHODS

The Influenza Complications Alert Network
The Influenza Complications Alert Network (FluCAN) is a national, hospital-based sentinel surveillance system for laboratory-confirmed influenza [26] . From 2014, prospective surveillance included 2 tertiary pediatric hospitals: Children's Hospital at Westmead in New South Wales and Princess Margaret Hospital in Western Australia, both part of the Paediatric Active Enhanced Disease Surveillance (PAEDS) network [27] . Prior to inclusion in prospective surveillance, a retrospective study at both sites captured all hospitalized cases of laboratory-confirmed influenza from 2011 to 2013.
Influenza cases were identified using screening of laboratory records and patient admission logs. Inclusion criteria were age <16 years, admitted to hospital with an acute respiratory illness (see Supplementary Data) and laboratory-confirmed influenza. Influenza testing was initiated by clinicians, using local guidelines, in accredited laboratories using standard polymerase chain reaction primers. Under FluCAN, surveillance is conducted during the Southern Hemisphere influenza season (April to October). Demographics, risk factors, clinical features, medications, and hospitalization details were collected [28] . Cases with neurological manifestations recorded as a presenting feature or complication were extracted for this analysis. Neurologic features or complications were defined as symptoms that affected the central and/or peripheral nervous system including seizures, encephalopathy, encephalitis, or any focal neurological symptom.
Ethics approval was obtained at all participating sites.
The Australian Childhood Encephalitis Study
Concurrently, prospective, hospital-based, sentinel site surveillance for acute childhood encephalitis using the PAEDS [27] network was conducted. [30, 31] as confirmed encephalitis (see Supplementary Data). Those cases not meeting the criteria for confirmed encephalitis are designated "not encephalitis" and include a variety of encephalitis-like syndromes. All cases from which influenza virus was identified during their acute illness were analyzed in this study.
Combined Analysis
Cases identified by either surveillance system were pooled and reidentified in order to remove duplicates and ensure complete ascertainment. Cases were categorized into 6 neurological syndrome subgroups based upon ACE expert panel, clinician diagnosis, and additional retrospective review of clinical documents. The subgroups included (see Supplementary Data): encephalitis/encephalopathy (IAE) [29] ; nonspecific encephalopathy; simple febrile seizure; other seizures; acute cerebellar ataxia; and other focal neurological features. Outcome at discharge was categorized based on clinician assessment as either full recovery or return to premorbid neurological function; incomplete recovery (ie, neurological deficits or reduced neurological function); or death. The proportion of hospitalized IAE and of all IAND was calculated. In addition, we estimated the annual incidence of childhood IAE in the 2 states under combined surveillance (New South Wales and Western Australia), using age-specific population data from the Australian Bureau of Statistics for the surveillance period midpoint (June 2014). Given the high proportion of IAE cases admitted to the intensive care unit (ICU), the population denominator was weighted by the proportion of state-wide pediatric ICU admissions received at each site (100% Western Australia, 48% New South Wales in 2014: http://www. anzics.com.au/Downloads/2014%20ANZPICR%20Annual%20 Report.pdf).
FluCAN identified 710 children admitted at the 2 PAEDS sites with laboratory-confirmed influenza over the 3 study years (2013) (2014) (2015) , of which 48 patients showed neurological features ( Figure 1 ). These included 9 children also identified by the ACE study, 6 with encephalitis/encephalopathy.
At the 5 PAEDS hospitals participating in the ACE study in 2013-2015, 342 children were identified with suspected encephalitis, of whom 23 had influenza identified on an acute specimen. Of these 23, 15 were admitted at the 2 sites also participating in FluCAN (Figure 1 ). In the additional cases uniquely identified by the ACE study, influenza testing was performed at an external hospital prior to transfer.
Burden of Disease
When data from ACE and FluCAN surveillance were combined (Figure 1 ), 7.6% (54/710) of children hospitalized for influenza over 3 seasons presented with IAND. IAE occurred in 1.4% (10/710) ( Figure 1 ; Table 1 ). We observed significant year-to-year variability in the frequency of influenza hospitalization and the proportion with IAND (Table 1) . Overall, the mean annual incidence (hospitalization rate) of IAE was 2.8 per 1 000 000 population aged ≤14 years and 6.5 per 1 000 000 aged ≤4 years.
Influenza-Associated Neurological Disease
We observed a variety of syndromes among the 54 cases of IAND in the combined dataset (Table 2) . At the most severe end of the disease spectrum were 10 cases of IAE including 6 with specific acute encephalopathy syndromes: 3 acute necrotizing encephalopathy, 2 acute encephalopathy with biphasic seizures and late diffusion restriction, and 1 mild encephalopathy with reversible splenial lesion. Six IAE cases were admitted to the ICU, 2 died, and 3 of 8 survivors suffered neurological sequelae (Table 2) .
Thirty (55%) cases were categorized as having an acute seizure. Fourteen were febrile seizures occurring most frequently in preschool-aged children who were otherwise well; all but 1 recovered fully. One child in this group died during admission, but attributable to a premorbid cardiac condition. In contrast, other children (n = 16) who presented with seizures showed a variety of seizure phenotypes with or without fever, 3 with status epilepticus. Thirteen of these children (81%) had preexisting neurological disorders and 7 (44%) other risk factors for severe influenza. In this group, 5 (31%) children had some qualitative short-term deterioration relative to premorbid function (increased seizure frequency [3] , need for additional antiepileptics [3] , weakness [1] , poor feeding [1] , sleep-wake disturbance [1] , agitation [1] ); all but 1 of these children had preexisting neurological disorders. A number of other syndromes were identified: acute ataxia, nonspecific encephalopathy, and focal neurological deficits (Tables 1 and 2 ). The majority of children recovered fully: all 4 (100%) children with acute ataxia, 6 children (86%) with nonspecific encephalopathy, and 2 children (67%) with other focal neurological deficits. Two of the cases in this final group were syndromes with probable immune-mediated pathogenesis (postinfectious myelitis, opsoclonus myoclonus) for which influenza can be considered a possible trigger, although the child with opsoclonus myoclonus was also receiving treatment for neuroblastoma.
Intensive care admissions occurred in a quarter of children (15/54); notably, all but 1 of these children had IAE or were children with seizures and a preexisting neurological disorder (2 status epilepticus). Overall, the majority of surviving children (41/51 [80%]) were reported to completely recover or return to premorbid function. Specific influenza antivirals were prescribed infrequently (17%) and only 2 (4%) children had received influenza vaccine (1 or more doses) in the calendar year of their admission. There was no statistical association of influenza type (A or B) with specific subgroups, although we note the higher frequency of seizure presentations in 2013 compared to 2014-2015; 2013 was an influenza A/H1N1-predominant year (see Table 1 footnote). Furthermore, we note that 2015 was an influenza B-predominant season in Australia, with an increased proportion of B/Victoria lineage viruses isolated nationally compared with 2013-2014.
Encephalitis and Encephalitis-like Syndromes
Twenty-three cases of suspected encephalitis were identified by the ACE study at 5 sites, all of which occurred during the Southern Hemisphere influenza season (May to October). Their full clinical data are contained in a Supplementary Table. Thirteen cases were categorized as meeting the definition of encephalitis by the expert panel. The remaining 10 cases were classified as "not encephalitis. "
The encephalitis cases had notable differences to the encephalitis-like syndromes. The encephalitis cases were younger (median age, 3.7 vs 7.4 years) and the majority were female (8/13 vs 4/10). Fewer encephalitis cases had preexisting neurological disease and medical comorbidities predisposing them to severe influenza (1/13 vs 5/10). The overall severity of disease (ICU admission, 9/13 vs 3/10) and outcome (death and neurological morbidity, 7/13 vs 1/10) were worse among encephalitis cases. In both groups, a third of cases did not present with an associated acute respiratory illness and, where cerebrospinal fluid (CSF) was sampled, the median white cell count was 1; only a minority (20%) showed CSF pleocytosis. In both groups, oseltamivir was prescribed infrequently. None had been vaccinated with the current season influenza vaccine.
DISCUSSION
We have shown that seasonal influenza is an important cause of neurological disease in Australian children. At the most severe end, IAE occurs in approximately 1% of influenza hospitalizations. The majority of these IAE cases can be categorized as specific acute encephalopathy syndromes. This finding supports that of Goenka et al who, in national surveillance (2011-2013), found that 6 of 7 encephalitis cases in children, 2 of whom died and 3 of whom suffered neurological morbidity, could be categorized as acute encephalopathy syndromes [7] . The point estimates of the incidence of IAE shown here are lower, but not significantly different from those reported from Japan [23] . Additionally, estimates from California during the 2009 pandemic for IAE in those aged ≤18 years ranged from 0.4-5.5 per 1 000 000, comparable to our estimate [8] . An older study from Sweden found a lower population incidence (0.21 per 1 000 000) across all ages based on International Classification of Diseases coding data [32] . Our findings show that IAE occurs consistently in association with seasonal influenza and outside East Asia. It is likely that it has been underrecognized in the past. In addition, the broader (5 sentinel site) ACE study data show that influenza is a leading cause of childhood encephalitis. To the end of 2015, influenza has been identified as the cause of 5% of all encephalitis cases (10% infectious encephalitis) and occurred in equal frequency with herpes simplex virus.
Apart from IAE, we have observed a broad spectrum of IAND including both acute and subacute syndromes. The spectrum of IAND associated with seasonal influenza is comparable to that described during the 2009 H1N1 pandemic. Active surveillance during the pandemic in Australian pediatric hospitals found a similar proportion of IAND (9.7% [49/506]; P = .08) among hospitalized influenza, 1.4% (7/506) with encephalitis/encephalopathy [33] . Seizures were the predominating feature (63%, Two of these cases identified by ACE study alone. c Fisher exact test, unless otherwise specified. Emboldened P-values reached pre-specified value for statistical significance <.05. half simple febrile seizures), 14% of cases were encephalitis/ encephalopathy, 20% other encephalopathy, and 4% paralysis/ Guillain-Barré syndrome [33] . A third of children in this pandemic cohort were admitted to ICU, and 2 of 49 cases died; 42% of children had preexisting neurological disease. Other cohorts of childhood IAND from the pandemic also show that seizures were the most common neurological complication, that preexisting neurological disease was a risk factor, and a minority are subacute immune-mediated syndromes (transverse myelitis, acute disseminated encephalomyelitis, Guillain-Barré syndrome) [11, 12, 16, 18, 20] . These features are also evident in nonpandemic cohorts [17, 34, 35] . Given the similar spectrum of disease between seasonal and pandemic influenza, and the frequency of influenza B among our cases and in East Asian studies, severe neurological disease should be considered with all influenza types/subtypes. We acknowledge that we were unable to determine whether specific subsyndromes associate with specific influenza subtypes in this study. In the few studies directly comparing IAND caused by seasonal and pandemic influenza, the only significant difference was that encephalopathy cases were more frequent, and occurred in older children during the pandemic [12, 14] .
Among those cases presenting with seizure, it is important to differentiate 3 distinct groups given different outcomes. The first group consists of well preschool-aged children with typical/ simple febrile seizures in whom full recovery can be expected. The second group is children with preexisting neurological disease, often complex epilepsy or neurodevelopmental disorders, who present with recurrent seizures or status epilepticus and often require intensive care; a minority of these cases do not fully recover premorbid function in the short-term. A third group are children with IAE who may present with seizure and (or evolve to show) additional neurological features. Magnetic resonance imaging in this group, in particular diffusion weighted imaging, is required to make an early diagnosis of specific acute encephalopathy syndromes where the risk of death or neurological morbidity is highest. Other viruses have been associated with the acute neurologic illnesses that make up the spectrum of IAND; however, given its frequency, predictable seasonality (in temperate environments) and the availability of vaccines and antivirals, we would emphasize the clinical importance of influenza.
Consistent with other studies, we found that the majority of children with IAE and IAND had not received seasonal influenza vaccination [7, 33] . This is explained by overall low rates of influenza vaccine uptake in children in Australia, which does not have a universally funded childhood influenza vaccine program [36, 37] . Under current Australian guidelines, influenza vaccination was not funded or specifically promoted for many of these children (except in Western Australia, where a state-funded preschool vaccination program exists, albeit with low coverage during the study period). The absence of medical comorbidities among children with IAE and other IAND supports the presence of universal vaccination policies present in select countries. The frequency of influenza B causing IAND in our study supports the introduction of quadrivalent vaccine that includes 2 influenza B strains into Australia in 2016. Although a study performed to show vaccine effectiveness against neurological manifestations of influenza is impractical due to low case numbers, we contend that many of the cases presented here would have been preventable. One ecological study from Japan showed that the mortality rate from IAE in children was significantly lower during the era of mass influenza immunization of children (pre-1994) than in a subsequent era (1995-2000) [38] .
Given the broad clinical spectrum of IAND, attempts have been made to standardize case classification [4, 39, 40] , but none of these classifications have been validated. The most recent, proposed by Goenka et al [7] , classifies cases by the timing of neurological symptoms relative to acute influenza infection and probability of adverse outcomes. These subgroups are correlated with putative pathogenic mechanisms. We have taken the observed frequencies of the spectrum of IAND observed here and populated the classification in Supplementary Figure 1 [7] . In addition, by accounting for the outcome data presented here and insights into pathogenesis of disease in the published literature, we have modified the categorization [4, [41] [42] [43] .
Our study has several limitations. First, the ACE study is observational and not all identified suspected encephalitis cases were tested for influenza. In particular, it is possible that influenza associated with subacute syndromes are underrepresented in this cohort due to the low frequency of testing (only 37% of ACE-identified acute disseminated encephalomyelitis tested for influenza) [44] . Furthermore, it is important to note that none of the ACE cases had testing for influenza in CSF specimens. Although influenza has only rarely been identified in central nervous system specimens, and we assume that neuroinvasion did not occur among these cases, we cannot be sure. Again, we acknowledge that because influenza subtyping was not performed on isolates from the majority of cases in this cohort, specific clinical associations with influenza subtypes cannot be identified. Finally, we note that additional cases identified by ACE were tested prior to transfer to the surveillance sites, which are tertiary/quaternary children's hospitals. It is possible that severe IAND is proportionally overrepresented in this cohort as a result of these selection biases. We have, however, adjusted for this in our IAE incidence estimates.
In conclusion, we have presented a description of the spectrum of IAND ascertained by 2 established surveillance networks at 2 children's hospitals in Australia over 3 seasons. We have shown that IAE is associated with a high morbidity and mortality. Influenza should be considered as a possible cause of encephalitis syndrome in all children presenting during influenza season; local encephalitis guidelines should consider inclusion of empiric treatment with oseltamivir while awaiting investigation results. We have calculated the contribution of IAE to hospitalized influenza and shown its incidence to be comparable to that in the 2009-2010 pandemic years and in East Asian populations. Furthermore, we have shown that IAND occurs primarily in children younger than 5 years and without preexisting neurological disease or other risk factors for severe influenza. These findings support the case for universal influenza vaccination in young children.
Supplementary Data
Supplementary materials are available at Clinical Infectious Diseases online. Consisting of data provided by the authors to benefit the reader, the posted materials are not copyedited and are the sole responsibility of the authors, so questions or comments should be addressed to the corresponding author.
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